Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
170.69
+2.81 (1.67%)
At close: Aug 21, 2026, 4:00 PM EDT
170.65
-0.04 (-0.02%)
After-hours: Aug 21, 2026, 7:30 PM EDT
Guardant Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,183 | 982.02 | 739.02 | 563.95 | 449.54 | 373.65 | |
Revenue Growth | 42.74% | 32.88% | 31.04% | 25.45% | 20.31% | 30.31% |
Cost of Revenue | 413.95 | 349.01 | 289.8 | 227.05 | 156.33 | 122.91 |
Gross Profit | 769.16 | 633.01 | 449.22 | 336.9 | 293.21 | 250.74 |
Selling, General & Admin | 862.4 | 705.12 | 544.05 | 450.92 | 463.78 | 398.52 |
Research & Development | 375.79 | 364.19 | 347.75 | 367.19 | 373.81 | 263.22 |
Operating Expenses | 1,238 | 1,069 | 891.8 | 818.11 | 837.59 | 661.74 |
Operating Income | -469.03 | -436.3 | -442.58 | -481.22 | -544.38 | -411 |
Interest Expense | -4.82 | -3.9 | -2.58 | -2.58 | -2.58 | -2.58 |
Interest & Investment Income | 38.77 | 34.1 | 53.69 | 35.37 | 6.07 | 3.93 |
Other Non Operating Income (Expenses) | 9.09 | 8.09 | 1.8 | 2.52 | -99.51 | 0.18 |
EBT Excluding Unusual Items | -425.99 | -398.01 | -389.68 | -445.91 | -640.4 | -409.47 |
Gain (Loss) on Sale of Investments | -13.58 | -18.58 | -44.4 | 50.66 | -13.05 | - |
Legal Settlements | - | - | - | -83.4 | - | - |
Other Unusual Items | -14.9 | -0.95 | -1.01 | -0.11 | - | 25 |
Pretax Income | -454.47 | -417.54 | -435.09 | -478.76 | -653.45 | -384.47 |
Income Tax Expense | -1.03 | -1.26 | 1.28 | 0.69 | 1.14 | 0.3 |
Earnings From Continuing Operations | -453.44 | -416.28 | -436.37 | -479.45 | -654.59 | -384.77 |
Minority Interest in Earnings | - | - | - | - | - | -20.9 |
Net Income | -453.44 | -416.28 | -436.37 | -479.45 | -654.59 | -405.67 |
Net Income to Common | -453.44 | -416.28 | -436.37 | -479.45 | -654.59 | -405.67 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 129 | 125 | 123 | 112 | 102 | 101 |
Shares Outstanding (Diluted) | 129 | 125 | 123 | 112 | 102 | 101 |
Shares Change | 4.62% | 2.14% | 9.61% | 9.60% | 0.85% | 3.91% |
EPS (Basic) | -3.50 | -3.32 | -3.56 | -4.28 | -6.41 | -4.00 |
EPS (Diluted) | -3.50 | -3.32 | -3.56 | -4.28 | -6.41 | -4.00 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -240.72 | -233.07 | -274.94 | -345.46 | -386.92 | -284.05 |
Free Cash Flow Per Share | -1.86 | -1.86 | -2.24 | -3.08 | -3.79 | -2.80 |
Gross Margin | 65.01% | 64.46% | 60.79% | 59.74% | 65.22% | 67.11% |
Operating Margin | -39.64% | -44.43% | -59.89% | -85.33% | -121.10% | -110.00% |
Profit Margin | -38.33% | -42.39% | -59.05% | -85.02% | -145.61% | -108.57% |
Free Cash Flow Margin | -20.35% | -23.73% | -37.20% | -61.26% | -86.07% | -76.02% |
EBITDA | -430.57 | -396.56 | -400.2 | -438.33 | -508.42 | -388.73 |
EBITDA Margin | -36.39% | -40.38% | -54.15% | -77.73% | -113.10% | -104.04% |
D&A For EBITDA | 38.46 | 39.74 | 42.39 | 42.88 | 35.96 | 22.27 |
EBIT | -469.03 | -436.3 | -442.58 | -481.22 | -544.38 | -411 |
EBIT Margin | -39.64% | -44.43% | -59.89% | -85.33% | -121.10% | -110.00% |
Revenue as Reported | - | - | - | - | 449.54 | 373.65 |
Advertising Expenses | - | - | - | - | - | 2.4 |